LOL , Rusty...that is Medimmune. This is Sanofi-REGN
Red...
Well Alirocumab is Ph 3 but lets wait to see what Choice 1 reveals. Dupilumab just came though very strong phase 2 studies. The others are Ph 1
If you want to talk near term I am hoping Secukinumab gets thrown into the UNS trolley. That would be a good near term drug to land. Much like Alirocumab.
That spreadsheet copy and paste are only the Sanofi drugs and there are 4 other particular pharma that I am watching to see which way they head. Some are nearer term in Ph 2. One of the ones that was very encouraging just got delayed due to lack of R&D funding and manufacturing capacity to produce clinical trial drug. Bugger.
So there are of course many more out there but I tend to only look at the ones I do because I am lazy and they are some of the easier programs to follow as multiple players in the same sand pit makes it easier vs a single pharma developing a drug
- Forums
- ASX - By Stock
- UNS
- New contract
New contract, page-27
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online